![](https://www.embl.org/news/wp-content/uploads/2024/07/2024-Proteomics-Data-Feature-v2-300x180.jpg)
Proteomics: a different lens for precision medicine
Perspectives, Science & Technology The dynamic world of proteomics is shaping the future of personalised medicine, but some obstacles stand in the way
2024
perspectivesscience-technology
Perspectives, Science & Technology The dynamic world of proteomics is shaping the future of personalised medicine, but some obstacles stand in the way
2024
perspectivesscience-technology
Lab Matters, People & Perspectives, Perspectives By upskilling researchers on bioinformatics skills and tools, EMBL alumna Emily Perry is helping to make genomic medicine more accessible.
2023
lab-matterspeople-perspectivesperspectives
Perspectives, Science, Science & Technology EMBL-EBI data resources are being used to deliver thousands of genetic diagnostics to patients every month.
2023
perspectivessciencescience-technology
Lab Matters, Science & Technology A new grant will provide a way for fundamental metabolomic research to realise its commercial potential and promise in aiding drug development and precision medicine.
2022
lab-mattersscience-technology
Science, Science & Technology If researchers can identify specifically when good cells go bad, they can potentially understand disease better.
2021
sciencescience-technology
Science, Science & Technology A research collaboration used machine learning to map tumour molecular make-up, potentially paving way to more customised cancer treatment.
2021
sciencescience-technology
Alumni, People & Perspectives EMBL alumnus Pawel Masiewicz has transferred skills and experience gained at EMBL to oversee starting materials for mRNA vaccine development.
2021
alumnipeople-perspectives
Lab Matters, Science & Technology A decadal roadmap points the way to cell-based medicine for Europe
2020
lab-mattersscience-technology
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive